Trials / Completed
CompletedNCT00169728
Vaccination of Children Following Allogeneic Stem Cell Transplantation
Immunogenicity of the DTaP-IPV-HBV/Hib Combination Vaccine Infanrix Hexa and the Heptavalent Pneumococcal Conjugate Vaccine Prevenar in Pediatric Recipients of Allogeneic Haematopoietic Stem Cell Transplantation
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 53 (actual)
- Sponsor
- Heinrich-Heine University, Duesseldorf · Academic / Other
- Sex
- All
- Age
- 17 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the immunogenicity and tolerability of the DTaP-IPV-HBV/Hib combination vaccine Infanrix hexa and the heptavalent pneumococcal conjugate vaccine Prevenar in pediatric recipients of allogeneic haematopoietic stem cell transplantation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | DTaP-IPV-HBV/Hib combination vaccine, Infanrix hexa | |
| BIOLOGICAL | heptavalent pneumococcal conjugate vaccine, Prevenar |
Timeline
- Start date
- 2003-09-01
- Primary completion
- 2006-06-01
- Completion
- 2006-10-01
- First posted
- 2005-09-15
- Last updated
- 2012-06-07
Locations
11 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT00169728. Inclusion in this directory is not an endorsement.